In addition, Withaar et al. [149] constructed a model with HFD and ANGII treatment, which exhibited higher levels of cardiac fibrosis as well as more severe diastolic dysfunction and cardiac hypertrophy compared to the single-treatment group with HFD or ANGII. The gene discussed is AGT; the disease is cardiac hypertrophy.